Mitragynine | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 398.5 g/mol [1] |
Appearance | White amorphous powder [1] |
Melting point | 104 °C [1] |
Boiling point | 235 °C [1] |
Solubility | Soluble in alcohol, chloroform, acetic acid [1] |
Predicted LogP | 3.4 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C23H30N2O4 [1] |
IUPAC name | methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate [1] |
SMILES | CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC [1] |
InChI | InChI=1S/C23H30N2O4/c1-5-14-12-25-10-9-15-21-18(7-6-8-20(21)28-3)24-22(15)19(25)11-16(14)17(13-27-2)23(26)29-4/h6-8,13-14,16,19,24H,5,9-12H2,1-4H3/b17-13+/t14-,16+,19+/m1/s1 [1] |
InChIKey | LELBFTMXCIIKKX-QVRQZEMUSA-N [1] |
Dosing [] | |
---|---|
Elimination half-life | 7 – 39 hours |
Mitragynine
Mitragynine (also known as Skf 12711, Mitragynin, 9-Methoxycorynantheidine, SK&F 12711, 16,17-Didehydro-9,17-dimethoxy-17,18-seco-20-α-yohimban-16-carboxylic acid methyl ester, kratom alkaloids, (αE,2s,3s,12βs)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-methoxy-α-(methoxymethylene)-indolo(2,3-a)quinolizine-2-acetic acid methyl ester, Indolo(2,3-a)quinolizine-2-acetic acid, 3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-methoxy-α-(methoxymethylene)-, methyl ester, (αe,2s,3s,12bs)-, methyl (2E)-2-[(2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),11,13,15-tetraen-4-yl]-3-methoxyprop-2-enoate or Methyl (2E)-2-((2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo(8.7.0.0,.0,)heptadeca-1(10),11(16),12,14-tetraen-4-yl)-3-methoxyprop-2-enoic acid) is a opioid substance of the β-carboline class.
Chemistry
Stereochemistry []
Mitragynine is a absolute mixture
Subjective effects
Anodyne Usernotes [] | |
---|---|
0xea / Mitragynine via | quite relaxing yet helpful for working; reduces minor pain; very helpful when crashing from <a href=/class/stimulant>Stimulants</a>; encourages sexuality |
Legal status
- Australia: Mitragynine is a S8 substance.
- Brazil: Mitragynine is a B1 substance.[3]
- Canada: Mitragynine is a Unscheduled substance.
- Germany: Mitragynine is a NPSG substance.
- New Zealand: Mitragynine is a Unscheduled substance.
- United Kingdom: Mitragynine is a PSA substance.
- United States: Mitragynine is a unscheduled substance.
- United Nations: Mitragynine is a unscheduled substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3034396, Mitragynine. Accessed June 28, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/3034396
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mitragynine. UNII: EP479K822J. Global Substance Registration System. Accessed June 28, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/EP479K822J
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed June 28, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992